Morning,castleevents.com,Rainy,/Apostolos8422.html,Some,$5,CDs Vinyl , Blues , Contemporary Blues Morning,castleevents.com,Rainy,/Apostolos8422.html,Some,$5,CDs Vinyl , Blues , Contemporary Blues Sales Some Rainy Morning $5 Some Rainy Morning CDs Vinyl Blues Contemporary Blues Sales Some Rainy Morning $5 Some Rainy Morning CDs Vinyl Blues Contemporary Blues

Sales Some Rainy Morning Sale price

Some Rainy Morning

$5

Some Rainy Morning

|||

Editorial Reviews

Product description

NEW Combo BLUWAVS CD and FLAC FILE

Amazon.com

It's easy to take Robert Cray for granted, for the singer-guitarist has altered his approach so little since he first burst on the scene. Nonetheless, the changes from his early albums to "i"Some Rainy Morning are no less real for having been subtle. Cray is still combining urban-blues guitar and Southern-soul vocals on stories of romantic treachery and working-class frustration, but he has distilled that strategy until nothing superfluous remains. "Some Rainy Morning," recorded with his stripped-down road quartet, is full of breathing room so Cray's singing and playing are set off more dramatically than ever. In addition to the eight originals by Cray and his bandmates, the album includes remakes of Wilson Pickett's "Jealous Love" and Syl Johnson's "Steppin' Out," and Cray does a great job of matching Pickett's raucous shouts and Johnson's silky crooning. On his own songs, Cray sounds better than ever when he's holding out notes for effect or communicating paradoxical emotions. When he proclaims, "I'll Go On" loving his ungrateful woman, you can hear the extreme effort such loyalty requires. And when he insists that his ex-lover "Never Mattered Much" to him, you can hear just how much her absence continues to tear at him. --Geoffrey Himes

Some Rainy Morning

CURRENT ISSUE
September, 2021

No. 106 (9)

2020 Impact Factor: 9.941 Submission > Acceptance: 52 days
ARTICLES IN THREE SENTENCES
Article

Long-term outcomes from the phase II L-MIND study of tafasitamab (MOR208) plus lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma

This open-label, single-arm study investigated the long-term efficacy of tafasitamab plus lenalidomide in 81 patients with relapsed/refractory diffuse large B-cell lymphoma. The response rate was 57.5%, including complete responses in 40.0% of patients, and the median duration of response was 43.9 months. This treatment is a valuable option for patients not eligible for autologous stem-cell transplantation.

Johannes Duell et al.

Case Report

Clinical genomic profiling of novel grey zone lymphoma paired lesions with sequential central nervous system involvement in two adolescent patients

Grey zone lymphoma is a B-cell lymphoma, unclassifiable, with features intermediate between those of large B-cell lymphoma and classic Hodgkin lymphoma. The in-depth study of the two adolescent patients described in this case report expands the clinicopathological and genomic spectrum of this rare pediatric disease. Moreover, it provides information on their response to treatment.

Cagla Y. Benkli et al.

Article

CAMT-MPL: congenital amegakaryocytic thrombocytopenia caused by MPL mutations - heterogeneity of a monogenic disorder - a comprehensive analysis of 56 patients

The clinical picture of 56 patients with congenital amegakaryocytic thrombocytopenia due to MPL mutations was much more varied than previously thought. Twenty-five per cent of them had no signs of thrombocytopenia at birth, and 50% had non-hematologic defects. Pancytopenia developed in (nearly) all patients and hematopoietic stem-cell transplantation was effective in 87% of cases.

Manuela Germeshausen et al.

Article

Oxidative stress activates red cell adhesion to laminin in sickle cell disease

Sickle red blood cells exhibit abnormal adhesion to laminin mediated by Lu/BCAM protein at their surface. This study provides evidence of the involvement of oxidative stress in post-translational modifications of Lu/BCAM which impact the protein’s distribution and cis-interaction with glycophorin C at the cell surface activating its adhesive function in dense sickle red cells. The authors speculate that antioxidant drugs might attenuate this phenomenon.

Maria Alejandra Lizarralde-Iragorri et al.

TAKE ADVANTAGE FROM HAEMATOLOGICA